Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term 80 and over Aged. Found 131 abstracts

no pagination
Burger RA, Brady MF, Bookman MA, Monk BJ, Walker JL, Homesley HD, Fowler J, Greer BE, Boente M, Fleming GF, Lim PC, Rubin SC, Katsumata N, Liang SX. Risk factors for GI adverse events in a phase III randomized trial of bevacizumab in first-line therapy of advanced ovarian cancer: A Gynecologic Oncology Group Study. J Clin Oncol. 2014 Apr 20;32(12):1210-7.   PMCID: Pmc3986384
Hurwitz MD, Ghanouni P, Kanaev SV, Iozeffi D, Gianfelice D, Fennessy FM, Kuten A, Meyer JE, LeBlang SD, Roberts A, Choi J, Larner JM, Napoli A, Turkevich VG, Inbar Y, Tempany CM, Pfeffer RM. Magnetic resonance-guided focused ultrasound for patients with painful bone metastases: phase III trial results. J Natl Cancer Inst. 2014 May;106(5).   PMCID: Pmc4112926
Johnson ME, Zhu F, Li T, Wu H, Galloway TJ, Farma JM, Perlis CS, Turaka A. Absolute lymphocyte count: a potential prognostic factor for Merkel cell carcinoma. J Am Acad Dermatol. 2014 Jun;70(6):1028-35.
Lango MN, Egleston B, Fang C, Burtness B, Galloway T, Liu J, Mehra R, Ebersole B, Moran K, Ridge JA. Baseline health perceptions, dysphagia, and survival in patients with head and neck cancer. Cancer. 2014 Mar 15;120(6):840-7.   PMCID: Pmc3951722
Martin LP, Sill M, Shahin MS, Powell M, DiSilvestro P, Landrum LM, Gaillard SL, Goodheart MJ, Hoffman J, Schilder RJ. A phase II evaluation of AMG 102 (rilotumumab) in the treatment of persistent or recurrent epithelial ovarian, fallopian tube or primary peritoneal carcinoma: a Gynecologic Oncology Group study. Gynecol Oncol. 2014 Mar;132(3):526-30.
Pisansky TM, Pugh SL, Greenberg RE, Pervez N, Reed DR, Rosenthal SA, Mowat RB, Raben A, Buyyounouski MK, Kachnic LA, Bruner DW. Tadalafil for prevention of erectile dysfunction after radiotherapy for prostate cancer: the Radiation Therapy Oncology Group [0831] randomized clinical trial. JAMA. 2014 Apr 02;311(13):1300-7.
Arrangoiz R, Papavasiliou P, Singla S, Siripurapu V, Li T, Watson JC, Hoffman JP, Farma JM. Partial stomach-partitioning gastrojejunostomy and the success of this procedure in terms of palliation. Am J Surg. 2013 Sep;206(3):333-9.   PMCID: No NIH funding
Meyer JE, Panico VJ, Marconato HM, Sherr DL, Christos P, Pirog EC. HIV positivity but not HPV/p16 status is associated with higher recurrence rate in anal cancer. J Gastrointest Cancer. 2013 Dec;44(4):450-5.   PMCID: Pmc3963822
Schilder RJ, Sill MW, Lankes HA, Gold MA, Mannel RS, Modesitt SC, Hanjani P, Bonebrake AJ, Sood AK, Godwin AK, Hu W, Alpaugh RK. A phase II evaluation of motesanib (AMG 706) in the treatment of persistent or recurrent ovarian, fallopian tube and primary peritoneal carcinomas: a Gynecologic Oncology Group study. Gynecol Oncol. 2013 Apr;129(1):86-91.   PMCID: PMC 3712785
Siddiqui AA, Chaaya A, Shelton C, Marmion J, Kowalski TE, Loren DE, Heller SJ, Haluszka O, Adler DG, Tokar JL. Utility of the short double-balloon enteroscope to perform pancreaticobiliary interventions in patients with surgically altered anatomy in a US multicenter study. Dig Dis Sci. 2013 Mar;58(3):858-64.   PMCID: No NIH funding
Gumbs AA, Tsai TJ, Hoffman JP. Initial experience with laparoscopic hepatic resection at a comprehensive cancer center. Surg Endosc. 2012 Feb;26(2):480-7.   PMCID: not NIH funded
Smaldone MC, Egleston B, Uzzo RG, Kutikov A. Does partial nephrectomy result in a durable overall survival benefit in the Medicare population?. J Urol. 2012 Dec;188(6):2089-94.
Turaka A, Parsons RB, Buyyounouski MK. Radiation therapy for pituitary metastasis: report of four cases. Tumori. 2012 Jan;98(1):e1-6.   PMCID: Not NIH funded
Canter D, Long C, Kutikov A, Plimack E, Saad I, Oblaczynski M, Zhu F, Viterbo R, Chen DY, Uzzo RG, Greenberg RE, Boorjian SA. Clinicopathological outcomes after radical cystectomy for clinical T2 urothelial carcinoma: further evidence to support the use of neoadjuvant chemotherapy. BJU Int. 2011 Jan;107(1):58-62.
Dees EC, Infante JR, Cohen RB, O'Neil BH, Jones S, von Mehren M, Danaee H, Lee Y, Ecsedy J, Manfredi M, Galvin K, Stringer B, Liu H, Eton O, Fingert H, Burris H. Phase 1 study of MLN8054, a selective inhibitor of Aurora A kinase in patients with advanced solid tumors. Cancer Chemother Pharmacol. 2011 Apr;67(4):945-54.   PMCID: PMC3026871
Kutikov A, Piotrowski ZJ, Canter DJ, Li T, Chen DY, Viterbo R, Greenberg RE, Boorjian SA, Uzzo RG. Routine adrenalectomy is unnecessary during surgery for large and/or upper pole renal tumors when the adrenal gland is radiographically normal. J Urol. 2011 Apr;185(4):1198-203.   PMCID: PMC3117661
Turaka A, Li T, Nicolaou N, Lango MN, Burtness B, Horwitz EM, Ridge JA, Feigenberg SJ. Use of a conventional low neck field (LNF) and intensity-modulated radiotherapy (IMRT): no clinical detriment of IMRT to an anterior LNF during the treatment of head-and neck-cancer. Int J Radiat Oncol Biol Phys. 2011 Jan;79(1):65-70.   PMCID: PMC3339153
Cristofanilli M, Valero V, Mangalik A, Royce M, Rabinowitz I, Arena FP, Kroener JF, Curcio E, Watkins C, Bacus S, Cora EM, Anderson E, Magill PJ. Phase II, randomized trial to compare anastrozole combined with gefitinib or placebo in postmenopausal women with hormone receptor-positive metastatic breast cancer. Clin Cancer Res. 2010 Mar 15;16(6):1904-14.   PMCID: NIHMS352308
Kutikov A, Uzzo RG, Caraway A, Reese CT, Egleston BL, Chen DY, Viterbo R, Greenberg RE, Wong YN, Raman JD, Boorjian SA. Use of systemic therapy and factors affecting survival for patients undergoing cytoreductive nephrectomy. BJU Int. 2010 Jul;106(2):218-23.   PMCID: PMC2906619
Lebed B, Jani SD, Kutikov A, Iffrig K, Uzzo RG. Renal masses herniating into the hilum: technical considerations of the "ball-valve phenomenon" during nephron-sparing surgery. Urology. 2010 Mar;75(3):707-10.   PMCID: PMC2992985
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term 80 and over Aged

Aged 80 and over Aged Middle Aged Female Adult Male pathology methods therapeutic use Retrospective Studies drug therapy adverse effects surgery Young Adult Local Neoplasm Recurrence mortality Treatment Outcome therapy Disease-Free Survival Neoplasm Staging Kidney Neoplasms Survival Rate etiology complications Renal Cell Carcinoma Antineoplastic Agents Prognosis radiotherapy Ovarian Neoplasms administration & dosage secondary Double-Blind Method Combined Modality Therapy Nephrectomy Prospective Studies Neoplasm Invasiveness Survival Analysis Fallopian Tube Neoplasms Peritoneal Neoplasms Squamous Cell Carcinoma Proportional Hazards Models blood Magnetic Resonance Imaging antagonists & inhibitors metabolism Epidemiologic Methods Neoplasms Head and Neck Neoplasms Deglutition Disorders Cohort Studies Lymph Node Excision Risk Assessment Antineoplastic Combined Chemotherapy Protocols utilization Follow-Up Studies diagnosis Palliative Care Protein Kinase Inhibitors pharmacokinetics United States Intensity-Modulated Radiotherapy chemically induced Immunoenzyme Techniques Maximum Tolerated Dose Cystectomy Headache Skin Neoplasms Adrenal Gland Neoplasms epidemiology Vascular Endothelial Growth Factor A Fatal Outcome head and neck cancer Multivariate Analysis Postmenopause radiography Breast Neoplasms Adjuvant Chemoradiotherapy Dose Fractionation Aurora Kinases Weight Loss Merkel Cell Carcinoma Non-Small-Cell Lung Carcinoma SEER Program Half-Life immune function Taxoids Gastrointestinal Diseases Length of Stay Pain Preoperative Care Prostatic Neoplasms High-Intensity Focused Ultrasound Ablation Protocols Urothelium Progesterone Receptors Disorders of Excessive Somnolence Confusion Liver genetics Double-Balloon Enteroscopy Medicare Viral DNA Psychological Adaptation adverse Radiotherapy Dosage Epidermal Growth Factor Receptor Merkel cell carcinoma Adenocarcinoma Oral Administration Urinary Bladder Neoplasms Nutritional Status Pancreas Papillomavirus Infections Reoperation effects Hepatectomy Quinazolines baseline weight loss Multiple Primary Neoplasms Adolescent Survival Case-Control Studies Medical Records Marriage Stereotaxic Techniques Neoplasm DNA Adrenal Glands immunology Benzazepines absolute lymphocyte count Pain Perception instrumentation Methylphenidate Estrogen Receptors Postoperative Complications Inflammatory Breast Neoplasms Antineoplastic Combined Chemotherapy Duodenal Obstruction Adjuvant Chemotherapy Adrenalectomy Treatment Failure Carbolines Perception Quality of Life physiology skin cancer Drug Dose-Response Relationship Self Report Linear Models Lymphocyte Count
Last updated on Wednesday, August 13, 2014